İsA Sevindi

İsA Sevindi

Auto-generated profile, based on publicly available information

İsA Sevindi

University of Health Sciences Turkey, İstanbul Training and Research Hospital, Clinic of Internal Medicine, Division of Gastroenterology, İstanbul, Turkey

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2023 in Molecular Imaging and Radionuclide Therapy
Verified
Journal Article
Open access
GTGamze Tatar
Gamze Tatar
EBEdiz Beyhan
Ediz Beyhan
ÖFÖzge Erol Fenercioğlu
Özge Erol Fenercioğlu
ISİsA Sevindi
İsA Sevindi
NENurhan Ergül
Nurhan Ergül
TÇTevfik Fikret Çermik
Tevfik Fikret Çermik
Fibroblast activation protein (FAP) is expressed as a pro-inflammatory agent from fibrous tissue in liver cirrhosis and in the tumor microenvironment. Cirrhosis is the last stage of any chronic liver disease, and the natural course of cirrhosis is the progression from the asymptomatic phase to the symptomatic decompensated phase with the development of ascites. Although various clinical features suggest cirrhosis in patients with chronic liver disease, non-invasive methods should follow the clinical approach before a definitive diagnosis. Herein, we present three cases of liver cirrhosis with fibroblast activation protein inhibitor (FAPI) uptake to demonstrate the usefulness of 68Ga-FAPI-04 positron emission tomography/computed tomography (PET/CT) scan in cirrhosis.